Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

View source ↗

Summary

A completed observational study sponsored by AbbVie evaluating the effects of Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on dry eye symptoms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) (NGE-UD)

Snippet

Sponsor: AbbVie | Conditions: Dry Eye | Status: COMPLETED